Abstract
Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery. Initial treatment with intravenous amphotericin B resulted in acute renal impairment. Despite 8 days of intravenous fluconazole therapy, he remained fungemic. Caspofungin was added to the treatment regimen with subsequent sterilisation of blood culture. The patient was treated for 34 days with caspofungin and 41 days with fluconazole. He continued oral fluconazole after hospital discharge and remained well at follow-up 11 months later. The role of fluconazole and caspofungin in the treatment of Candida endocarditis is discussed.
Similar content being viewed by others
References
Pappas PG, Rex JH, Sobel JD, et al. (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38:161–189
Groll AH, Kolve H (2004) Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. Eur J Clin Microbiol Infect Dis 23:256–270
Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W (2001) Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 32:50–62
Pierrotti LC, Baddour LM (2002) Fungal endocarditis, 1995–2000. Chest 122:302–310
Muehrcke DD, Lytle BW, Cosgrove III DM (1995) Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 60:538–543
Melgar GR, Nasser RM, Gordon SM, Lytle BW, Keys TF, Longworth DL (1997) Fungal prosthetic valve endocarditis in 16 patients: an 11-year experience in a tertiary care hospital. Medicine (Baltimore) 76:94–103
Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M (1996) Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis 22:262–267
Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46:1773–1780
Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL (2002) In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46:3634–3636
Rubinstein E, Noriega ER, Simberkoff MS, Rahal JJ (1974) Tissue penetration of amphotericin B in Candida endocarditis. Chest 66:376–377
Czwerwiec FS, Bilsker MS, Kamerman ML, Bisno AL (1993) Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis. Am J Med 94:545–546
Longman LP, Hibbert SA, Martin MV (1990) Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis. Rev Infect Dis 16:794–798
Pfaller MA, Diekema DJ, Messer SA, Hollis RJ, Jones RN (2003) In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother 47:1068–1071
Pfaller MA, Messer SA, Boyken L, et al. (2003) Caspofungin activity against clinical isolates of fluconazole-resistant Candida. J Clin Microbiol 41:5729–5731
Mora-Duarte J, Betts R, Rotstein C, et al. (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020–2029
Mrowczynski W, Wojtalik M (2004) Caspofungin for Candida endocarditis. Pediatr Infect Dis J 23:376
Jimenez-Exposito MJ, Torres G, Baraldes A, et al. (2004) Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment. Clin Infect Dis 39:e70–73
Prabhu RM, Orenstein R (2004) Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis. Clin Infect Dis 39:1253–1254
Deresinski SC, Stevens DA (2003) Caspofungin. Clin Infect Dis 36:1445–1457
Antoniadou A, Kontoyiannis DP (2003) Status of combination therapy for refractory mycoses. Curr Opin Infect Dis 16:539–545
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lye, D.C.B., Hughes, A., O'Brien, D. et al. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis 24, 753–755 (2005). https://doi.org/10.1007/s10096-005-0038-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-005-0038-2